I haven't been a follower of OKN and only just took a quick look.
Given the falling revenues of last few years, I would have thought market would want to see real evidence of return to growth. Maybe a good enough/firm forecast at HY will be sufficient, but seems more likely it might be closer to FY before there will be any impetus behind them.
Hast there been any discussion around exec director remuneration? I was surprised to see the huge increases and relatively high base salaries given that they were reducing staff elsewhere in the business. Not surprising to see about 17% of votes against adopting the remuneration report at agm.
Overall, I currently value around $2.50, but would not be interested in buying until risk decreases - i.e. review after HY result.
- Forums
- ASX - By Stock
- OKN
- Ann: OKN MARKET UPDATE
Ann: OKN MARKET UPDATE , page-8
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OKN (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online